» Articles » PMID: 31111668

Cholangiocarcinoma: State-of-the-art Knowledge and Challenges

Overview
Journal Liver Int
Specialty Gastroenterology
Date 2019 May 22
PMID 31111668
Citations 11
Authors
Affiliations
Soon will be listed here.
Citing Articles

Research hotspots and trends in immunotherapy for cholangiocarcinoma: a bibliometric analysis (2014-2023).

Qu X, Wang Q, Zhu F, Liang H, Long Z, Wu Y Front Immunol. 2024; 15:1436315.

PMID: 39660136 PMC: 11628549. DOI: 10.3389/fimmu.2024.1436315.


Overcoming treatment resistance in cholangiocarcinoma: current strategies, challenges, and prospects.

Wang J, Liu S, Cao Y, Chen Y Front Cell Dev Biol. 2024; 12:1408852.

PMID: 39156971 PMC: 11327014. DOI: 10.3389/fcell.2024.1408852.


Strategies for treating the cold tumors of cholangiocarcinoma: core concepts and future directions.

Zhang G, Li J, Li G, Zhang J, Yang Z, Yang L Clin Exp Med. 2024; 24(1):193.

PMID: 39141161 PMC: 11324771. DOI: 10.1007/s10238-024-01460-7.


Generation of Metastatic Cholangiocarcinoma Patient-Derived Xenograft Models.

Yanez-Bartolome M, Serra-Camprubi Q, Arenas E, Escorihuela M, Castet F, Fabregat-Franco C Methods Mol Biol. 2024; 2806:139-151.

PMID: 38676801 DOI: 10.1007/978-1-0716-3858-3_11.


A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers.

Barbato A, Piscopo F, Salati M, Pollastro C, Evangelista L, Ferrante L Clin Exp Med. 2024; 24(1):74.

PMID: 38598008 PMC: 11006774. DOI: 10.1007/s10238-024-01332-0.